CBD for pets has become one of the fastest-growing segments of the cannabis market. An estimated 1 in 5 pet owners has tried CBD for their animals, yet veterinarians have been largely unable to discuss it due to regulatory constraints. As the evidence base grows and regulations evolve, here's what the science actually shows.
Yes — all mammals, birds, reptiles, and fish have endocannabinoid systems. Dogs and cats have CB1 and CB2 receptors distributed similarly to humans, though with some important differences. Dogs in particular have a higher density of CB1 receptors in the cerebellum than humans, which makes them more sensitive to THC's neurological effects — explaining why THC toxicity in dogs can cause severe ataxia (loss of coordination) even at doses that would be mildly intoxicating in humans.
CBD, which does not directly activate CB1 receptors, does not carry this toxicity risk. Dogs metabolize CBD differently than humans — they have lower bioavailability from oral CBD and may require different dosing strategies — but the compound itself is not toxic to dogs at therapeutic doses.
A 2018 Cornell University study (Gamble et al.) — the first randomized, placebo-controlled trial of CBD in dogs — found that 2mg/kg CBD twice daily significantly reduced pain scores and improved mobility in dogs with osteoarthritis, with no adverse effects. A 2022 follow-up study confirmed these findings. This is the most robust evidence for CBD in any veterinary application.
A 2019 Colorado State University study found that 89% of dogs receiving CBD in a clinical trial had a reduction in seizure frequency. A 2021 study found CBD as an add-on therapy reduced seizure frequency by 33% in dogs with drug-resistant epilepsy. The mechanism mirrors human epilepsy — CBD modulates neuronal excitability through multiple pathways.
Survey data consistently shows pet owners report CBD helps with anxiety (noise phobia, separation anxiety, situational anxiety). Controlled trial data are limited. A 2020 study found CBD reduced stress behaviors in shelter dogs. The anxiolytic mechanism is plausible given CBD's effects on serotonin and GABA systems, but more rigorous trials are needed.
Preclinical data suggest CBD has anti-tumor properties in various cancer cell lines, but no controlled veterinary trials have been completed. Anecdotal reports of CBD helping with chemotherapy-induced nausea in dogs are consistent with the known antiemetic mechanism, but clinical evidence is lacking.
Starting dose: 0.5–1mg CBD per kg body weight, twice daily
Therapeutic dose (pain/seizures): 2mg/kg twice daily (based on Cornell study)
Route: Oral oil added to food or given directly — best absorbed with a fatty meal
Onset: 30–60 minutes for acute effects; 2–4 weeks for full anti-inflammatory benefit
Monitoring: Liver enzymes (ALT) should be checked at baseline and after 3 months of use — CBD can elevate liver enzymes in some dogs
Always consult your veterinarian before starting CBD, especially if your pet takes other medications.
The FDA has not approved any CBD products for veterinary use, and the American Veterinary Medical Association (AVMA) has called for more research. In many states, veterinarians are legally prohibited from recommending cannabis products to clients — though this is changing as more states pass veterinary cannabis bills. The result is a market where pet owners are largely self-directing CBD use without professional guidance. This makes independent education — and the importance of veterinary consultation — especially critical.